Literature DB >> 30596344

Management of hyponatremia: causes, clinical aspects, differential diagnosis and treatment.

Alessandro Peri1.   

Abstract

INTRODUCTION: Hyponatremia is the most frequent electrolyte disorder in hospitalised patients. Acute and severe hyponatremia may be a life-threatening situation. However, also mild and chronic hyponatremia may negatively affect the health status (i.e. gait disturbances, attention deficits, falls and fractures, and bone loss) and may increase the risk of death. Therefore, it is of paramount importance for clinicians to have an in-depth knowledge on this topic, in order to appropriately manage patients affected by hyponatremia. AREAS COVERED: This review will cover different areas related to this electrolyte disorder. Because many pathologic conditions may be associated with hyponatremia, thorough investigations have to be performed in order to establish the underlying etiology. To establish the cause of hyponatremia is of great importance, because an appropriate therapeutic strategy is strictly dependent on a correct diagnosis. A description of the different available therapeutic approaches for the correction of hyponatremia, including vaptans, will follow. EXPERT COMMENTARY: Undoubtedly, the studies that have been published in recent years and the introduction of vaptans in clinical practice have contributed to increase the awareness on hyponatremia among clinicians. Nevertheless, additional studies are needed in order to clarify some partially uncovered areas.

Entities:  

Keywords:  Hyponatremia; SIAD; saline solution; sodium; vaptans

Mesh:

Substances:

Year:  2018        PMID: 30596344     DOI: 10.1080/17446651.2019.1556095

Source DB:  PubMed          Journal:  Expert Rev Endocrinol Metab        ISSN: 1744-6651


  8 in total

Review 1.  Approach to the Patient: Hyponatremia and the Syndrome of Inappropriate Antidiuresis (SIAD).

Authors:  Julie Martin-Grace; Maria Tomkins; Michael W O'Reilly; Chris J Thompson; Mark Sherlock
Journal:  J Clin Endocrinol Metab       Date:  2022-07-14       Impact factor: 6.134

2.  Oxcarbazepine and Hyponatremia.

Authors:  Julija Čiauškaitė; Giedrė Gelžinienė; Giedrė Jurkevičienė
Journal:  Medicina (Kaunas)       Date:  2022-04-19       Impact factor: 2.948

3.  Higher plasma NT-proBNP levels correlate with syndrome of inappropriate antidiuretic hormone and poor prognosis in neurological patients.

Authors:  Qing-Ling Zeng; Wen-Tao He; Gang Yuan
Journal:  Ann Transl Med       Date:  2021-01

Review 4.  A narrative review of progress in diagnosis and treatment of small cell lung cancer patients with hyponatremia.

Authors:  Ranpu Wu; Chuling Li; Zimu Wang; Hang Fan; Yong Song; Hongbing Liu
Journal:  Transl Lung Cancer Res       Date:  2020-12

Review 5.  Apelin and Vasopressin: The Yin and Yang of Water Balance.

Authors:  Pierre-Emmanuel Girault-Sotias; Romain Gerbier; Adrien Flahault; Nadia de Mota; Catherine Llorens-Cortes
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-22       Impact factor: 5.555

6.  Clinical efficacy of urea treatment in syndrome of inappropriate antidiuretic hormone secretion.

Authors:  Eva Perelló-Camacho; Francisco J Pomares-Gómez; Luis López-Penabad; Rosa María Mirete-López; María Rosa Pinedo-Esteban; José Ramón Domínguez-Escribano
Journal:  Sci Rep       Date:  2022-06-17       Impact factor: 4.996

7.  Asymptomatic syndrome of inappropriate secretion of antidiuretic hormone (SIADH) following duloxetine treatment for pain with depression: Two case reports.

Authors:  Aoi Sato; Norio Yasui-Furukori; Yumiko Oda; Misa Yang; Yudai Suzuki; Masataka Shinozaki; Taro Shimizu; Kazutaka Shimoda
Journal:  Neuropsychopharmacol Rep       Date:  2022-06-22

8.  Prevalence and Prognostic Significance of Hyponatremia in Patients With Lung Cancer: Systematic Review and Meta-Analysis.

Authors:  Eszter Bartalis; Marin Gergics; Benedek Tinusz; Mária Földi; Szabolcs Kiss; Dávid Németh; Margit Solymár; Zsolt Szakács; Péter Hegyi; Emese Mezösi; László Bajnok
Journal:  Front Med (Lausanne)       Date:  2021-12-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.